# ProPhase Labs (PRPH) Stock Price, News & Catalysts
Canonical URL: https://biopharmsignal.com/company/PRPH
## Company Profile
- Ticker: PRPH
- Exchange: NASDAQ
- Sector: Biopharma
- Location: United States
## Stock Data
- Close: 0.0176 USD
- Market cap: Not available USD
- Last updated: 2026-09-08
## Business Overview
ProPhase Labs is a diagnostics and consumer-health company with exposure to testing, wellness, and specialty products. Its business is more diversified and opportunistic than a conventional biotech model.
## Why The Stock Is Moving

As of Sep 8, 2026, PRPH closed down 12.0% at $0.0176. No new same-company headline was identified in the current news window.

## Geographic Base

Headquartered in the United States and listed on NASDAQ, ProPhase sits in consumer health and diagnostics.

## Business Model

The company depends on product and test adoption, commercial execution, and the ability to monetize a small portfolio of assets.

## Landscape Position

ProPhase is outside biotech proper and belongs to the consumer-diagnostics and health-products layer.

## Future Catalysts

- ProPhase Labs’ catalysts are diagnostics and consumer-health execution, plus any strategic update that clarifies the company’s next direction. Investors will care about whether the business can find a stable growth path.

## Recent News
- 2026-04-15 13:05 EST — [ProPhase Labs Reports Year-End 2025 Results, Highlights Accelerating Settlement Activity and Investment-Ready Crown Medical Collections Platform](https://biopharmsignal.com/news/PRPH/prophase-labs-reports-year-end-2025-results-highlights-accelerating-settlement-activity-and-investment-ready-crown-medical-collections-platform) — Source: ProPhase Labs
- 2026-03-17 12:00 EST — [ProPhase Labs Provides Business Update Highlighting Advancing Crown Medical Collections Activity](https://biopharmsignal.com/news/PRPH/prophase-labs-provides-business-update-highlighting-advancing-crown-medical-collections-activity) — Source: ProPhase Labs
- 2026-02-03 12:00 EST — [ProPhase Labs Initiates Potential Sale or Strategic Partnership of BE-Smart™ and Advances Crown Medical Collections Initiative](https://biopharmsignal.com/news/PRPH/prophase-labs-initiates-potential-sale-or-strategic-partnership-of-be-smarttm-and-advances-crown-medical-collections-initiative) — Source: ProPhase Labs
- 2026-02-02 13:00 EST — [Join ProPhase Labs’ Exclusive Live Investor Webinar and Q&A Session on February 3rd](https://biopharmsignal.com/news/PRPH/join-prophase-labs-exclusive-live-investor-webinar-and-qanda-session-on-february-3rd) — Source: ProPhase Labs
- 2026-01-26 12:00 EST — [ProPhase Labs Provides Crown Medical Collections Update; 250+ Insurance Payors Engaged, Approximately 50 Matters in Advanced Settlement Posture](https://biopharmsignal.com/news/PRPH/prophase-labs-provides-crown-medical-collections-update-250-insurance-payors-engaged-approximately-50-matters-in-advanced-settlement-posture) — Source: ProPhase Labs